Rubius Therapeutics (STU:5RT) LT-Debt-to-Total-Asset : 0.00 (As of Dec. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Rubius Therapeutics LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Rubius Therapeutics's long-term debt to total assests ratio for the quarter that ended in Dec. 2022 was 0.00.

Rubius Therapeutics's long-term debt to total assets ratio declined from Dec. 2021 (0.33) to Dec. 2022 (0.00). It may suggest that Rubius Therapeutics is progressively becoming less dependent on debt to grow their business.

Rubius Therapeutics LT-Debt-to-Total-Asset Historical Data

The historical data trend for Rubius Therapeutics's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rubius Therapeutics LT-Debt-to-Total-Asset Chart

Rubius Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.14

0.22

0.39

0.33

Rubius Therapeutics Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.33	0.39	0.45	0.60	-

Rubius Therapeutics LT-Debt-to-Total-Asset Calculation

Rubius Therapeutics's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2022 is calculated as

LT Debt to Total Assets (A: Dec. 2022 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2022 )	/	Total Assets (A: Dec. 2022 )
	=	0	/	21.778
	=

Rubius Therapeutics's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2022 is calculated as

LT Debt to Total Assets (Q: Dec. 2022 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2022 )	/	Total Assets (Q: Dec. 2022 )
	=	0	/	21.778
	=

Rubius Therapeutics (STU:5RT) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Rubius Therapeutics LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Rubius Therapeutics's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Rubius Therapeutics (STU:5RT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rubius Therapeutics Inc (STU:5RT) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

124 Washington Street, Suite 101, Foxborough, MA, USA, 02035

Website

https://www.rubiustx.com

Rubius Therapeutics Inc develops red cell therapeutics (RCTs) for the treatment of patients with rare diseases, cancer, and autoimmune diseases.

Rubius Therapeutics (STU:5RT) Headlines

No Headlines